Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Manley

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Ethiopian Medical Journal|April 1, 1996
Helicobacter pylori, gastritis and non-ulcer dyspepsia in Ethiopian patientsE Tsega, W Gebre, P Manley, et al.
Trends in Pharmacological Sciences|June 1, 1992
Active enantiomers may cause adverse effects in asthmaI D Chapman, K H Buchheit, P Manley, et al.
American Journal of Veterinary Research|October 1, 1977
Telemetric measurements of strain in the metacarpus of the horse: a pilot studyG Sumner-Smith, M Bell, P Manley, et al.
Biopolymers|July 1, 1982
Dissociation of bovine and bacterial catalases by sodium n-dodecyl sulfateM N Jones, P Manley, P J Midgley, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 14, 2000
Atypical effect of minoxidil sulphate on guinea pig airwaysK H Buchheit, A Hofmann, P Manley, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 1, 1994
Ingrowth reduces implant-to-bone relative displacements in canine acetabular prosthesesJ P Heiner, P Manley, S Kohles, et al.
British Journal of Cancer|June 21, 2019
Correction: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.
British Journal of Cancer|May 25, 2006
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.
Epidemiology and Infection|May 8, 2019
Decreasing case fatality rate following invasive pneumococcal disease, North East England, 2006-2016C Houseman, K E Chapman, P Manley, et al.
Internal Medicine Journal|April 15, 2015
Long-term effectiveness of a community-based model of care in Māori and Pacific patients with type 2 diabetes and chronic kidney disease: a 4-year follow up of the DElay Future End Stage Nephropathy due to Diabetes (DEFEND) studyJ Tan, P Manley, G Gamble, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Ethiopian Medical Journal|April 1, 1996
Helicobacter pylori, gastritis and non-ulcer dyspepsia in Ethiopian patientsE Tsega, W Gebre, P Manley, et al.
Trends in Pharmacological Sciences|June 1, 1992
Active enantiomers may cause adverse effects in asthmaI D Chapman, K H Buchheit, P Manley, et al.
American Journal of Veterinary Research|October 1, 1977
Telemetric measurements of strain in the metacarpus of the horse: a pilot studyG Sumner-Smith, M Bell, P Manley, et al.
Biopolymers|July 1, 1982
Dissociation of bovine and bacterial catalases by sodium n-dodecyl sulfateM N Jones, P Manley, P J Midgley, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 14, 2000
Atypical effect of minoxidil sulphate on guinea pig airwaysK H Buchheit, A Hofmann, P Manley, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 1, 1994
Ingrowth reduces implant-to-bone relative displacements in canine acetabular prosthesesJ P Heiner, P Manley, S Kohles, et al.
British Journal of Cancer|June 21, 2019
Correction: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.
British Journal of Cancer|May 25, 2006
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.
Epidemiology and Infection|May 8, 2019
Decreasing case fatality rate following invasive pneumococcal disease, North East England, 2006-2016C Houseman, K E Chapman, P Manley, et al.
Internal Medicine Journal|April 15, 2015
Long-term effectiveness of a community-based model of care in Māori and Pacific patients with type 2 diabetes and chronic kidney disease: a 4-year follow up of the DElay Future End Stage Nephropathy due to Diabetes (DEFEND) studyJ Tan, P Manley, G Gamble, et al.
Pageof 4